A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON)
Clinical trial NCT01300247 · COMPLETED
Trial details
- NCT number
- NCT01300247
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-01-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.